Company / Current Assets
Xenetic Biosciences, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$8.0M
FY2025
5-year range
$6.6M / $18.7M
FY2021-FY2025
Trend
+22.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets returned to growth in FY2025 after 3 years of decline, reaching $8M.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of -8.2%.
Declined from $10M to $8M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -16.1%
- 5-Year CAGR
- -8.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -8.2%, indicating a declining trend.
- In FY2025, current assets increased 22.2% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.0M | +22.2% |
| FY2024 | $6.6M | -31.3% |
| FY2023 | $9.6M | -29.8% |
| FY2022 | $13.7M | -27.1% |
| FY2021 | $18.7M | +51.4% |
| FY2020 | $12.4M | +11.5% |
| FY2019 | $11.1M | +828.8% |
| FY2018 | $1.2M | -79.7% |
| FY2017 | $5.9M | -29.4% |
| FY2016 | $8.3M | +56.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026